Cancer Medicines Value in Context: PhRMA Report May 2019 - A slide resource kit
PhRMA released its Cancer Medicines Value in Context slide deck. It is a rich cache of data and slides resources on the current cancer market.
Click on image to download full deck of slide resources.
The key take aways from the deck:
We have made remarkable progress in the fight against the more than 200 diseases we call cancer and current research holds enormous promise to address the great unmet need.
Too many cancer patients face financial burdens, and these comes from a variety of sources including treatment costs, non-medical costs, and insurance benefit design.
The cost of cancer treatment comes from a range of sources including medicines, hospital and ED visits, diagnostics, and physician services.
The oncology market is working to control spending on cancer medicines and overall treatment costs.
Reforms are needed to accelerate the development path for cancer medicines and promote a delivery system that is increasingly patient-centered and value- based.